Role of Social Media in Diabetes Management in the Middle East Region: Systematic Review
- PMID: 29439941
- PMCID: PMC5829453
- DOI: 10.2196/jmir.9190
Role of Social Media in Diabetes Management in the Middle East Region: Systematic Review
Abstract
Background: Diabetes is a major health care burden in the Middle East region. Social networking tools can contribute to the management of diabetes with improved educational and care outcomes using these popular tools in the region.
Objective: The objective of this review was to evaluate the impact of social networking interventions on the improvement of diabetes management and health outcomes in patients with diabetes in the Middle East.
Methods: Peer-reviewed articles from PubMed (1990-2017) and Google Scholar (1990-2017) were identified using various combinations of predefined terms and search criteria. The main inclusion criterion consisted of the use of social networking apps on mobile phones as the primary intervention. Outcomes were grouped according to study design, type of diabetes, category of technological intervention, location, and sample size.
Results: This review included 5 articles evaluating the use of social media tools in the management of diabetes in the Middle East. In most studies, the acceptance rate for the use of social networking to optimize the management of diabetes was relatively high. Diabetes-specific management tools such as the Saudi Arabia Networking for Aiding Diabetes and Diabetes Intelligent Management System for Iraq systems helped collect patient information and lower hemoglobin A1c (HbA1c) levels, respectively.
Conclusions: The reviewed studies demonstrated the potential of social networking tools being adopted in regions in the Middle East to improve the management of diabetes. Future studies consisting of larger sample sizes spanning multiple regions would provide further insight into the use of social media for improving patient outcomes.
Keywords: Middle East; Saudi Arabia; cell phone; eHealth; mobile phone; outcome of care; social media; telemedicine.
©Turki Alanzi. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 13.02.2018.
Conflict of interest statement
Conflicts of Interest: None declared.
References
-
- Remedi MS, Emfinger C. Pancreatic β-cell identity in diabetes. Diabetes Obes Metab. 2016 Sep;18 Suppl 1:110–6. doi: 10.1111/dom.12727. http://europepmc.org/abstract/MED/27615139 - DOI - PMC - PubMed
-
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047–53. - PubMed
-
- Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003 Jan;52(1):102–10. http://diabetes.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=12502499 - PubMed
-
- Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009 Jun;32(6):1092–7. doi: 10.2337/dc08-1800. http://europepmc.org/abstract/MED/19279302 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
